Profile
Jakob Felding is currently Chief Science Officer at Bioporto A, starting in 2026.
Dr. Felding holds a doctorate from the University of Copenhagen.
Jakob Felding active positions
| Companies | Position | Start |
|---|---|---|
| BIOPORTO A/S | Chief Tech/Sci/R&D Officer | 01/04/2026 |
Training of Jakob Felding
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Bioporto A/S
Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Jakob Felding
















